Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000398322

Medchemexpress LLC bFGF (119-126) | 152051-61-1 | 99.93% | 993.16 | 10 MG
SDP

Catalog No. 5000398322
Encompass_Preferred

bFGF (119-126) is a ligand of basic fibroblast growth factor (bFGF) that inhibits its interaction with fibroblast growth factor receptor 1 (FGFR1). This suppresses FGFR1 phosphorylation and downstream signaling, leading to cell apoptosis and inhibition of proliferation, migration, angiogenesis, and metastasis. It can enhance cellular uptake when conjugated with a carrier and has shown enhanced tumor inhibitory effects in combination with ultrasound and Doxorubicin, useful in various cancer research.

  • Enhances cellular uptake via FGFR-mediated endocytosis when conjugated with a carrier
  • Effective FGFR-targeted ligand
  • Enhances tumor inhibitory effects when combined with ultrasound and Doxorubicin
  • Applicable for research in lung, breast, glioblastoma, and ovarian cancers.

Catalog No. 50-003-98322 Supplier Medchemexpress LLC Supplier No. HYP532110MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

bFGF (119-126) is a ligand of basic fibroblast growth factor (bFGF) that inhibits its interaction with fibroblast growth factor receptor 1 (FGFR1). This suppresses FGFR1 phosphorylation and downstream signaling, leading to cell apoptosis and inhibition of proliferation, migration, angiogenesis, and metastasis. It can enhance cellular uptake when conjugated with a carrier and has shown enhanced tumor inhibitory effects in combination with ultrasound and Doxorubicin, useful in various cancer research.

  • Enhances cellular uptake via FGFR-mediated endocytosis when conjugated with a carrier
  • Effective FGFR-targeted ligand
  • Enhances tumor inhibitory effects when combined with ultrasound and Doxorubicin
  • Applicable for research in lung, breast, glioblastoma, and ovarian cancers.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.